Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia. - Wikidata - wikimedia - TriplyDB

Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia.

Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia.

http://www.wikidata.org/entity/Q34919573

about

Circulating biomarkers to monitor cancer progression and treatment Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use Circulating microRNAs: potential biomarkers for common malignancies miRNAs associated with prostate cancer risk and progression Quantitative and stoichiometric analysis of the microRNA content of exosomes Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer.Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans.Multiple functions of hypoxia-regulated miR-210 in cancer.Noncoding RNAs as novel biomarkers in prostate cancer.Non-coding RNAs as clinical biomarkers for cancer diagnosis and prognosis.Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer Regulation of cancer metastasis by cell-free miRNAs.MicroRNA-572 improves early post-operative cognitive dysfunction by down-regulating neural cell adhesion molecule 1.Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.Imaging active urokinase plasminogen activator in prostate cancer.Assay reproducibility in clinical studies of plasma miRNA Signaling by exosomal microRNAs in cancer.SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer MicroRNA-375 plays a dual role in prostate carcinogenesis The biology and treatment of oligometastatic cancer.Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine RNA biomarkers to facilitate the identification of aggressive prostate cancer A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer Development of a circulating miRNA assay to monitor tumor burden: From mouse to man Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.Role of microRNA-210 in human intervertebral disc degeneration A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Epigenetic biomarkers in the blood of patients with urological malignancies.Regulation of miR-200c and miR-141 by Methylation in Prostate Cancer.MRP1 and its role in anticancer drug resistance.The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.The roles of microRNAs in the progression of castration-resistant prostate cancer.MiR200c targets IRS1 and suppresses prostate cancer cell growth.The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma.

P2860

Q26745985-D61BD1CA-FFCA-4C6D-8B30-D4B579CD0E3F Q26748872-433D77C6-AD7C-4DED-A613-580AA4298A00 Q26774431-65156636-EFF5-49A8-8F82-BF543D52E69B Q26774456-A7FB1DBD-1DE7-48E2-B158-30F31A5EE7EC Q26861185-E6BAAC85-9DDA-467B-A7F1-B75E10239265 Q28081347-431F7FA5-CE9C-4D62-8755-BBD5DD04EBE9 Q30235186-D9D2FC11-5358-4559-A7E1-385D9B369935 Q30594844-9E5D989D-2EBC-45D9-84F1-5AE7088F15B8 Q33613644-356D087F-514A-40D0-8440-37C4709FF4D3 Q33746984-D5A8AB2E-B7E5-49AE-B686-537075F346E9 Q33765128-48330FA7-BA1B-4279-A481-27D793E5CFDE Q34176890-9D01900B-2479-4CD1-8808-106EF5251360 Q34404162-0B4079AF-FF67-4290-A295-6E5428D76DB9 Q34614989-54967817-E78F-4BA2-862D-320707AB09F7 Q35034340-C6087100-735A-4E72-9E81-6062A6DE2738 Q35101632-A707A62E-5734-4A18-AC6E-810B4B743EB3 Q35110766-1B437FCF-68F5-41D2-905E-2A4FE133F03F Q35251858-F4E59909-012A-401E-8A4A-61BA870356A2 Q35325816-FEEDF69E-042F-40FC-A25F-66508570C3A0 Q35344075-A328BAE7-F342-4259-AB11-E5760D1D3520 Q35563844-DE18927A-54DB-49BC-8D65-7B8744F765FA Q35606022-4A74E5FF-833F-4132-A062-B7DD3AAE68B2 Q35832153-305B4CDB-A48B-4C0D-9D72-85DDB0CB478F Q36052700-4B1738BA-C0EE-4A14-85E1-972422A38874 Q36260364-ABEE2D28-5BE8-4CC1-ABA3-79325B4A966D Q36407203-C39F0786-8184-4814-B776-8F5AFFB60B73 Q36571424-64633E77-5B5E-441C-9B7C-FA03F8933833 Q36750985-39EA0EB9-9229-4319-B5DB-B37187E05AD0 Q36931205-A9901EBB-2A6B-49A6-B562-0786BEA4DDC2 Q36953296-3A1E9575-3377-40CC-8D8F-0EB03C132BD4 Q37499747-74BEB8FE-BE86-4A35-BB93-11BFB9CDE391 Q38216129-DFBF305E-944A-4897-BE1F-3B0B06DBF184 Q38365422-23767177-3F9D-4700-BDF4-C94DBDB8AECE Q38380233-82F465FC-B042-4794-AAEC-1C1FB518C79A Q38626237-900BC577-D007-4338-8C96-677FCF7DB878 Q38681199-4AD4BCE7-57C2-49EB-8CFF-B1B77FC39D80 Q38833395-A4FDD2C4-4D87-4674-83D4-F2DF5EACC92C Q38859577-A3A6C31B-6336-47D2-99A4-5ADE9FCA9EB0 Q38909442-C86337D6-32D6-47BC-A6B8-672E5B9A4856 Q38959811-C6D83CE2-E548-4756-B5DE-0D56293BA8B6

P2860

Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia.

http://www.wikidata.org/entity/Q34919573

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@ast

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@en

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@nl

type

label

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@ast

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@en

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@nl

prefLabel

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@ast

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@en

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@nl

P1433

Q34919573-DF7950D0-9C12-4571-88A6-6B872BDCAAE1

P1476

Q34919573-5B076D0E-636F-46E8-A689-5895CDCF2082

P2093

Q34919573-0B38E27E-6631-404A-80B6-8ED57F4D3CE6

Q34919573-11F87321-F231-44F9-B36E-409210CA6774

Q34919573-30C9F90D-E3B7-4F81-90CE-819BEAFFFB18

Q34919573-34349815-B650-4233-A484-E3E16F3086A4

Q34919573-515B582D-5CA8-421A-9CBB-EB20ECF3F701

Q34919573-5D72F586-CA92-486F-814D-2650562F701F

Q34919573-87D2EBD3-C196-4D58-986F-30AF69156C5C

Q34919573-8CA3222D-BA3C-4478-8967-561B57B53B8E

Q34919573-9029E3DE-0B5D-4CD7-AA40-7226F66FEC70

Q34919573-93AB533C-1804-4062-884D-E5821608219A

P2860

Q34919573-17CE0E00-9375-498B-86E0-042A9C7E9BB2

Q34919573-24E1F875-B2EE-4BF1-83F2-5B84896E763B

Q34919573-313977A3-460F-49AB-9746-7E242DCCCA7D

Q34919573-35826B18-7610-45F5-B436-6421382DFDF1

Q34919573-49685272-AFE8-405E-80DE-6D1963CC3194

Q34919573-4AAD21EA-722E-403C-B509-0942CE95C13F

Q34919573-5AB979F8-3E1F-450B-9C7E-D4A5AF99BB50

Q34919573-62EF64F6-5D7D-4A65-82E4-60869AE1610B

Q34919573-65A7876A-C821-4145-9092-2A2A3EA5C90C

Q34919573-6FDCE648-34C3-44C8-B3B3-A3E62F8D4B23

P304

Q34919573-E37699F3-48C8-4F8D-BDC2-F2CD6A909A70

P31

Q34919573-88CE7EBE-B0E1-4871-881B-C58335CEC4A1

P356

Q34919573-CFA3FE58-36D5-4062-8E59-9457FD2792CF

P407

Q34919573-84C0A6B7-ADCA-4F6E-A6F1-AB4312F7192A

P433

Q34919573-98B9C0F7-AA91-4857-B4FD-34229D63A533

P478

Q34919573-DF356743-B47D-4A60-86CA-2D19A9D67526

P577

Q34919573-477976DA-E872-46E8-9DF7-E1FAF200785B

P5875

Q34919573-5740B753-D082-4F00-8CE3-D00A9B48EDC3

P698

Q34919573-4F2854FF-7711-4F50-8ADB-9EC88A5280BA

P921

Q34919573-89F77601-6FD9-4791-9F5A-04642FF741CA

Q34919573-DA6C4B97-7BED-49E8-9AC8-DED9E7B8D143

P932

Q34919573-59E477D7-6F50-455E-926D-EDFC6762AB36

P356

JOURNAL.PONE.0069239

P1433

P1476

Circulating microRNA profiling ...... of cancer-associated hypoxia.

@en

P2093

Alexander E Dowell

http://www.w3.org/2001/XMLSchema#string

Arul M Chinnaiyan

http://www.w3.org/2001/XMLSchema#string

Beatrice S Knudsen

http://www.w3.org/2001/XMLSchema#string

Colm Morrissey

http://www.w3.org/2001/XMLSchema#string

Evan M Kroh

http://www.w3.org/2001/XMLSchema#string

Heather H Cheng

http://www.w3.org/2001/XMLSchema#string

Javed Siddiqui

http://www.w3.org/2001/XMLSchema#string

Kenneth J Pienta

http://www.w3.org/2001/XMLSchema#string

Lisly Chéry

http://www.w3.org/2001/XMLSchema#string

Muneesh Tewari

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

mir-210: a sensor for hypoxic stress during tumorigenesis

MiR-210--micromanager of the hypoxia pathway

Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

Circulating microRNAs as stable blood-based markers for cancer detection.

A microRNA signature of hypoxia

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

MicroRNA expression profiles classify human cancers

MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

P304

e69239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0069239

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255737122

http://www.w3.org/2001/XMLSchema#string

P698

23935962

http://www.w3.org/2001/XMLSchema#string

P921

P932

3728349

http://www.w3.org/2001/XMLSchema#string